Timothy P. Coughlin, Chief Financial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 70,000 shares at $16.75 ($1.2M) on 2014-01-07, disclosed to the SEC on 2014-01-08.
Scheduled sale ($1.2M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NBIX | SELL | 2017-01-18 | $142K | — | Filing → |
| NBIX | SELL | 2017-01-12 | $152K | — | Filing → |
| FATE | BUY | 2016-11-28 | $300K | — | Filing → |